We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 138

Aventis Pharma S.A. & Sanofi-Aventis U.S., LLC v. Hospira, Inc. et al., Nos. 07-CV-0721 & 08-CV-0496 (Fed. Cir. April 9, 2012)
  • Winston & Strawn LLP
  • USA
  • April 11 2012

Inequitable conduct finding affirmed on the merits after Therasense, and claim construction and obviousness rulings upheld where appellant's proposed construction required imposing limitations not required by the claims or other intrinsic evidence


3M Co. v. Avery Dennison Corp., No. 2011-1339 (Fed. Cir. Mar. 26, 2012)
  • Winston & Strawn LLP
  • USA
  • April 11 2012

The patentee’s identification of products that “may infringe” its patent, suggestion that licenses are available, and indication that it will provide claim charts may create a justiciable controversy sufficient to establish declaratory judgment jurisdiction


Regents of the University of Minnesota v. ADA Medical Corp., No. 2012-1167 (Fed. Cir. June 3, 2013).
  • Winston & Strawn LLP
  • USA
  • June 14 2013

An earlier prosecution disclaimer applies to a later application so long as the two have the same or closely related claim limitation language


Dey, L.P. et al. v. Sunovion Pharm., Inc., No. 2012-1428 (Fed. Cir. May 20, 2013).
  • Winston & Strawn LLP
  • USA
  • May 30 2013

Clinical drug trials operating under standard confidentiality procedures do not constitute a third-party public use under pre-America Invents Act


Accent Packaging, Inc. v. Leggett & Platt, Inc
  • Winston & Strawn LLP
  • USA
  • February 15 2013

A claim construction must not exclude the preferred embodiments, the possibility of altering an accused device to meet claim limitations does not


Motiva, LLC v. Int’l Trade Comm’n, No. 2012-1252 (Fed. Cir. May 13, 2013).
  • Winston & Strawn LLP
  • USA
  • May 24 2013

In an ITC proceeding, previous litigation of a patent by the complainant does not constitute a substantial investment in licensing to satisfy the


Forrester Envtl. Servs., Inc., v. Wheelabator Techs., Inc., No. 2012-1686 (Fed. Cir. May 16, 2013).
  • Winston & Strawn LLP
  • USA
  • May 24 2013

State law tortious interference and trade secret misappropriation claims did not raise a "substantial question of federal patent law" authorizing


Norgren, Inc. v. International Trade Commission, No. 2011-1349 (Fed. Cir. Nov. 14, 2012)
  • Winston & Strawn LLP
  • USA
  • November 29 2012

A patentee appealed the International Trade Commission’s determination that an accused infringer’s importation and sale of clamp devices did not violate section 337 of the Tariff Act of 1930


Intel Corp. v. Negotiated Data Solution, Inc. et. Al., no. 2011-1448 (Fed. Cir. Dec. 17, 2012).
  • Winston & Strawn LLP
  • USA
  • December 26 2012

A broad patent license, without language to the contrary, extends to reissue patents that are granted after the term of the license agreement. The


Sciele Pharma Inc. v. Lupin Ltd., No. 2012-1228 (Fed. Cir. July 2, 2012)
  • Winston & Strawn LLP
  • USA
  • July 26 2012

Defendants’ burden of proof for invalidity is not raised because a reference was previously before the PTO; statements made during prosecution to rebut enablement rejections under Section 112 may be used as proof of motivation to combine references under Section 103